ArticleFrontiers in medicine2020

Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19.

Ricardo Wesley Alberca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.